> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Oxitec GE Mosquito Release
- URL: https://www.fdaweb.com/comments-sought-on-oxitec-ge-mosquito-release/
- Published: 2016-03-14T12:00:00.000Z
- Updated: 2026-09-15T02:43:22.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135068

*Federal Register* Notice: FDA is making available for public comment the draft environmental assessment submitted by Oxitec Ltd. and a preliminary finding of no significant impact in support of an investigational release of OX513A Aedes aegypti genetically-engineered mosquitoes under an investigational new animal drug exemption. It is a part of an existing mosquito control program in Key Haven, FL. The strain of *Ae. aegypti* mosquito’s recombinant DNA construct encodes a conditional lethality trait such that the offspring of the matings of male OX513A mosquitoes and wild type Ae. aegypti do not survive to adulthood with the intended result of a decrease in the overall population of *Ae. aegypti* in the environment. Comments should be submitted by 4/13\. To view this notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-03-14/pdf/2016-05622.pdf?ref=fdaweb.com).